CABA
Cabaletta Bio Inc.
Company Overview
| Mkt Cap | $250.61M | Price | $3.61 |
| Volume | 35.91M | Change | +46.15% |
| P/E Ratio | -2.2 | Open | $2.61 |
| Revenue | -- | Prev Close | $2.47 |
| Net Income | $-115.9M | 52W Range | $0.99 - $5.46 |
| Div Yield | N/A | Target | $11.56 |
| Overall | 50 | Value | 60 |
| Quality | -- | Technical | 41 |
No chart data available
Stock Overview
Updated DailyCabaletta Bio Inc. (CABA) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $3.61 with a market capitalization of $250.61 million. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CABA with a volume of 35.91 million shares. The stock opened up 5.67% from yesterday's close of $2.47. Current analyst estimates project earnings of $-2.17 per share for this year, with next year targeting $-1.78.
CABA demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for CABA include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 220.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 03:53 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CABA | $3.61 | +46.2% | 35.91M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |